BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33422435)

  • 1. Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure.
    Bachmann KN; Gupta DK; Xu M; Brittain E; Farber-Eger E; Arora P; Collins S; Wells QS; Wang TJ
    JACC Heart Fail; 2021 Mar; 9(3):192-200. PubMed ID: 33422435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of natriuretic peptide non-response in patients hospitalized with acute heart failure.
    Ribeiro A; Lourenço P; Silva S; Cunha F; Vilaça J; Gomes F; Araújo JP; Bettencourt P
    Am J Cardiol; 2015 Jan; 115(1):69-74. PubMed ID: 25456879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
    Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
    Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction.
    Anjan VY; Loftus TM; Burke MA; Akhter N; Fonarow GC; Gheorghiade M; Shah SJ
    Am J Cardiol; 2012 Sep; 110(6):870-6. PubMed ID: 22681864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
    Zile MR; Desai AS; Agarwal R; Bharmi R; Dalal N; Adamson PB; Maisel AS
    Clin Cardiol; 2020 Dec; 43(12):1501-1510. PubMed ID: 32949178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.
    Anand IS; Claggett B; Liu J; Shah AM; Rector TS; Shah SJ; Desai AS; O'Meara E; Fleg JL; Pfeffer MA; Pitt B; Solomon SD
    JACC Heart Fail; 2017 Apr; 5(4):241-252. PubMed ID: 28359411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    York MK; Gupta DK; Reynolds CF; Farber-Eger E; Wells QS; Bachmann KN; Xu M; Harrell FE; Wang TJ
    J Am Coll Cardiol; 2018 May; 71(19):2079-2088. PubMed ID: 29747827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
    Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in low natriuretic peptide levels: Implications for heart failure clinical trials.
    Gangavelli A; Liu Z; Wang J; Okoh A; Steinberg R; Patel K; Pandey A; Gupta DK; Dickert N; Patel SA; Morris AA
    Am Heart J; 2023 Nov; 265():1-10. PubMed ID: 37343812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
    Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
    Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery.
    St Peter JV; Hartley GG; Murakami MM; Apple FS
    Clin Chem; 2006 Apr; 52(4):680-5. PubMed ID: 16497939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.
    El-Saed A; Voigt A; Shalaby A
    Clin Cardiol; 2009 Nov; 32(11):E33-8. PubMed ID: 19816874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.